Tarang Krishna
Breast cancer is one of the most common cancers in women. World Health Organization estimated the number of diagnosed breast cancer cases at approximately 2.1 million in 2018. This equals to about 11.6% of the total cancer incidence burden1. Globally, the incidence rates of breast cancer are much higher as compared to other cancers. Such high prevalence of breast cancer calls for an effective treatment that is able to resolve the condition permanently. Although the best form of resolution is early diagnosis but an assured treatment should be sought as most of the cases get detected in advanced stages. The potential side effects of chemotherapy and radiotherapy make them a non viable option in the treatment of breast cancer. The treatments of hormone therapy and targeted therapy are also not devoid of side effects. The treatment should be such that relieves the ailment of the patient rather than augmenting it. Another form of treatment that has emerged to treat various forms of cancer including breast cancer is immunotherapy and it is still in the stage of clinical trials. Many studies have been conducted in relation to the treatment of metastatic breast cancer with immunotherapy but none has been plausible in removing the disease entirely from the body and the possibility of emergence of alternate effects has also not been entirely ruled out. This case report aims to establish the efficacy of oral immunotherapy treatment in a patient of metastatic breast cancer in terms of the following: 1) Relieving the patient of her presenting complaints. 2) Removing the evidence of the disease completely from the body. 3) Ruling out relapse of the disease. 4) Ensuring a normal life to the patient.
PDFShare this article
Journal of Integrative Oncology received 495 citations as per Google Scholar report
